Literature DB >> 30573912

Computed Tomography Findings for Diagnosing Follicular Thyroid Neoplasms.

Takuma Makino1, Yorihisa Orita, Tomoyasu Tachibana, Hidenori Marunaka, Kentaro Miki, Naoki Akisada, Yusuke Akagi, Yoshiyuki Usui, Yasuharu Sato, Tadashi Yoshino, Kazunori Nishizaki.   

Abstract

Since no diagnostic method has been established to distinguish follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA), surgery has been the only way to reach a diagnosis of follicular neoplasm. Here we investigated the computed tomography (CT) features of follicular neoplasms, toward the goal of being able to identify specific CT features allowing the preoperative differentiation of FTC from FTA. We retrospectively analyzed the cases of 205 patients who underwent preoperative CT of the neck and were histopathologically diagnosed with FTC (n=31) or FTA (n=174) after surgery between January 2002 and June 2016 at several hospitals in Japan. In each of these 205 cases, non-enhanced and contrast-enhanced CT images were obtained, and we analyzed the CT features. On univariate analysis, inhomogeneous features of tumor lesions on contrast-enhanced CT were more frequently observed in FTC than in FTA (p=0.0032). A multivariate analysis identified inhomogeneous features of tumor lesions on contrast-enhanced CT images as an independent variable indicative of FTC (p=0.0023). CT thus offers diagnostic assistance in distinguishing FTC from FTA.

Entities:  

Keywords:  computed tomography; follicular thyroid adenoma; follicular thyroid carcinoma; preoperative diagnosis

Mesh:

Year:  2018        PMID: 30573912     DOI: 10.18926/AMO/56375

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  1 in total

1.  Ultrasonographic characteristics of thyroid metastasis from clear cell renal cell carcinoma: A case report.

Authors:  Peng Tian; Wenyan Du; Xiaoxi Liu; Wenzhe Xu; Xiaoyue Rong; Zekai Zhang; Yanzhen Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.